A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Abroad (travel likely)Recruiting
Conditions
Movement Disorders · Neurology · Parkinsons Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Maryland, Baltimore, Baltimore, Maryland, United States
Contact: Principal Investigator (Howard Eisenberg, MD)Weill Cornell Medicine, New York, New York, United States
Contact: Principal Investigator (Michael Kaplitt, MD PhD)University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Casey Halpern, MD)University of Texas Southwestern Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (Bhavya Shah, MD)Ohnishi Neurological Center, Akashi, Hyōgo, Japan
Contact: Principal Investigator (Yoshihiro Kuga, MD)